InvestorsHub Logo
Followers 8
Posts 250
Boards Moderated 0
Alias Born 01/21/2014

Re: ptk123 post# 31317

Tuesday, 07/29/2014 8:33:17 PM

Tuesday, July 29, 2014 8:33:17 PM

Post# of 44319
Great idea!

Too many of the factual messages exposing problems with XUII quick scroll off the front page due to too many positive posts by pumpers referencing incorrect facts, outdated press releases, etc. I would love to have a balanced set of message about all the problems and failures of XUII pinned to the top.

Some data to include in the sticky posts:
1. Share price down over 95% while Adam Radly has been CEO.
2. Only seven Imerjn tablets sold during the first two plus weeks they were available on Amazon.
3. Tablets were nearly six months late to market. Due by January 2014, not released for sale until July 2014.
4. A week after RMT purchase, still no visible reference to the acquisition by Imerjn on the RMT website.
5. Shares outstanding now over 1.2 billion.
6. Announced XUII acquisitions of NTIH and Trakkers either never completed or undone.
7. Check out the share price track record of INVA. Guess who was there as an employee or director - XUII CEO Adam Radly, XUII Contractor CFO Bob Bates, XUII Director Jeff Mandelbaum. What a winning (or maybe "losing" is the right term) team.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.